206 related articles for article (PubMed ID: 11820977)
1. [In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].
Losada I; Cañizares A; Hellín T; Martí-Belda P; Guerrero A
Enferm Infecc Microbiol Clin; 2002 Jan; 20(1):25-7. PubMed ID: 11820977
[TBL] [Abstract][Full Text] [Related]
2. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
3. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.
Safrin S; Elbeik T; Phan L; Robinson D; Rush J; Elbaggari A; Mills J
Antimicrob Agents Chemother; 1994 Jun; 38(6):1246-50. PubMed ID: 8092821
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
5. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
Levin MJ; Weinberg A; Leary JJ; Sarisky RT
Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
[TBL] [Abstract][Full Text] [Related]
6. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
8. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
9. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
Safrin S; Elbeik T; Mills J
J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
11. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
12. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
Safrin S; Phan L
Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
[TBL] [Abstract][Full Text] [Related]
14. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
[TBL] [Abstract][Full Text] [Related]
15. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E
J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
18. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
20. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]